nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—IKBKB—Sulfasalazine—ankylosing spondylitis	0.451	0.541	CbGbCtD
Arsenic trioxide—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0655	0.0785	CbGbCtD
Arsenic trioxide—CYP1B1—Dexamethasone—ankylosing spondylitis	0.0622	0.0745	CbGbCtD
Arsenic trioxide—ABCC2—Dexamethasone—ankylosing spondylitis	0.0327	0.0392	CbGbCtD
Arsenic trioxide—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0282	0.0338	CbGbCtD
Arsenic trioxide—CYP1A1—Dexamethasone—ankylosing spondylitis	0.0273	0.0327	CbGbCtD
Arsenic trioxide—ABCC2—Methotrexate—ankylosing spondylitis	0.0263	0.0315	CbGbCtD
Arsenic trioxide—ABCB1—Betamethasone—ankylosing spondylitis	0.0183	0.022	CbGbCtD
Arsenic trioxide—ABCB1—Prednisolone—ankylosing spondylitis	0.0181	0.0217	CbGbCtD
Arsenic trioxide—ABCB1—Prednisone—ankylosing spondylitis	0.0171	0.0205	CbGbCtD
Arsenic trioxide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0169	0.0202	CbGbCtD
Arsenic trioxide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0128	0.0153	CbGbCtD
Arsenic trioxide—CYP3A4—Betamethasone—ankylosing spondylitis	0.011	0.0132	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0108	0.013	CbGbCtD
Arsenic trioxide—ABCB1—Dexamethasone—ankylosing spondylitis	0.0107	0.0128	CbGbCtD
Arsenic trioxide—CYP3A4—Prednisone—ankylosing spondylitis	0.0102	0.0123	CbGbCtD
Arsenic trioxide—ABCB1—Methotrexate—ankylosing spondylitis	0.00856	0.0103	CbGbCtD
Arsenic trioxide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00639	0.00765	CbGbCtD
Arsenic trioxide—TXNRD1—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.000276	0.041	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000272	0.0405	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000272	0.0405	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Dexamethasone—ankylosing spondylitis	0.000272	0.0404	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Betamethasone—ankylosing spondylitis	0.000272	0.0404	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000268	0.0398	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000268	0.0398	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000266	0.0396	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Triamcinolone—ankylosing spondylitis	0.000265	0.0394	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000262	0.0389	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000262	0.0389	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000262	0.0389	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000262	0.0389	CbGdCrCtD
Arsenic trioxide—TXNRD1—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000256	0.0381	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisone—ankylosing spondylitis	0.000252	0.0374	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisone—ankylosing spondylitis	0.000248	0.0369	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisone—ankylosing spondylitis	0.000248	0.0369	CbGdCrCtD
Arsenic trioxide—TXNRD1—Flunisolide—Prednisolone—ankylosing spondylitis	0.000246	0.0365	CbGdCrCtD
Arsenic trioxide—JUN—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000243	0.036	CbGdCrCtD
Arsenic trioxide—JUN—Betamethasone—Prednisolone—ankylosing spondylitis	0.000243	0.036	CbGdCrCtD
Arsenic trioxide—TXNRD1—Testosterone—Prednisolone—ankylosing spondylitis	0.000232	0.0345	CbGdCrCtD
Arsenic trioxide—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000227	0.00143	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000226	0.00143	CbGpPWpGaD
Arsenic trioxide—MAPK3—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.000226	0.00143	CbGpPWpGaD
Arsenic trioxide—AKT1—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.000226	0.00142	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000225	0.00142	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CARD9—ankylosing spondylitis	0.000223	0.00141	CbGpPWpGaD
Arsenic trioxide—MAPK1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000223	0.0014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000222	0.0014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000222	0.0014	CbGpPWpGaD
Arsenic trioxide—JUN—TGF-beta Receptor Signaling—TNF—ankylosing spondylitis	0.000221	0.00139	CbGpPWpGaD
Arsenic trioxide—IKBKB—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.00022	0.00139	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KIR3DL1—ankylosing spondylitis	0.00022	0.00138	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00022	0.00138	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000219	0.00138	CbGpPWpGaD
Arsenic trioxide—MAPK3—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.000219	0.00138	CbGpPWpGaD
Arsenic trioxide—JUN—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000217	0.00137	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—IL1A—ankylosing spondylitis	0.000217	0.00137	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—CD79A—ankylosing spondylitis	0.000216	0.00136	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000216	0.00136	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.000215	0.00136	CbGpPWpGaD
Arsenic trioxide—MAPK1—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.000215	0.00136	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CARD9—ankylosing spondylitis	0.000215	0.00135	CbGpPWpGaD
Arsenic trioxide—IKBKB—TNF receptor signaling pathway —TNF—ankylosing spondylitis	0.000213	0.00134	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000212	0.00134	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000211	0.00133	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KIR3DL1—ankylosing spondylitis	0.00021	0.00132	CbGpPWpGaD
Arsenic trioxide—AKT1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000209	0.00132	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000209	0.00132	CbGpPWpGaD
Arsenic trioxide—MAPK1—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.000208	0.00131	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CARD9—ankylosing spondylitis	0.000208	0.00131	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000207	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—HLA-B—ankylosing spondylitis	0.000206	0.0013	CbGpPWpGaD
Arsenic trioxide—MAPK3—TGF-beta Receptor Signaling—TNF—ankylosing spondylitis	0.000206	0.0013	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000205	0.00129	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000205	0.00129	CbGpPWpGaD
Arsenic trioxide—AKT1—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	0.000203	0.00128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000203	0.00128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000203	0.00128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000202	0.00127	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—IL1A—ankylosing spondylitis	0.000202	0.00127	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000201	0.00126	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000201	0.00126	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.0002	0.00126	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000199	0.00125	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000199	0.00125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.000199	0.00125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CARD9—ankylosing spondylitis	0.000198	0.00125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000195	0.00123	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000193	0.00122	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000193	0.00121	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000192	0.00121	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—IL1A—ankylosing spondylitis	0.000192	0.00121	CbGpPWpGaD
Arsenic trioxide—MAPK3—Interferon Signaling—HLA-A—ankylosing spondylitis	0.000191	0.00121	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00019	0.0012	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CARD9—ankylosing spondylitis	0.00019	0.00119	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000189	0.00119	CbGpPWpGaD
Arsenic trioxide—JUN—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000188	0.00119	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000186	0.00117	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000185	0.00116	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000184	0.00116	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000184	0.00116	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000181	0.00114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000175	0.0011	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000169	0.00107	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000168	0.00106	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000168	0.00106	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000168	0.00106	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000167	0.00105	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ANTXR2—ankylosing spondylitis	0.000167	0.00105	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000164	0.00103	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ANTXR2—ankylosing spondylitis	0.000162	0.00102	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000161	0.00101	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.00016	0.00101	CbGpPWpGaD
Arsenic trioxide—JUN—Apoptosis—TNF—ankylosing spondylitis	0.000155	0.000978	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ANTXR2—ankylosing spondylitis	0.000154	0.000969	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000153	0.000963	CbGpPWpGaD
Arsenic trioxide—MAPK3—Alzheimers Disease—TNF—ankylosing spondylitis	0.000152	0.000957	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1R2—ankylosing spondylitis	0.00015	0.000946	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—ankylosing spondylitis	0.000149	0.000939	CbGpPWpGaD
Arsenic trioxide—AKT1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000149	0.000939	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000148	0.000934	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000146	0.000919	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.000145	0.000916	CbGpPWpGaD
Arsenic trioxide—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000145	0.000911	CbGpPWpGaD
Arsenic trioxide—MAPK1—Alzheimers Disease—TNF—ankylosing spondylitis	0.000144	0.00091	CbGpPWpGaD
Arsenic trioxide—JUN—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000144	0.000909	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1R2—ankylosing spondylitis	0.000144	0.000909	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERAP1—ankylosing spondylitis	0.000142	0.000897	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-C—ankylosing spondylitis	0.00014	0.000884	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1R2—ankylosing spondylitis	0.00014	0.000881	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000139	0.000874	CbGpPWpGaD
Arsenic trioxide—AKT1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000139	0.000873	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000138	0.000869	CbGpPWpGaD
Arsenic trioxide—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000138	0.000867	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERAP1—ankylosing spondylitis	0.000137	0.000862	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000135	0.0201	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000135	0.0201	CbGdCrCtD
Arsenic trioxide—AKT1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000135	0.00085	CbGpPWpGaD
Arsenic trioxide—MAPK3—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000134	0.000847	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1R2—ankylosing spondylitis	0.000133	0.000839	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000133	0.0197	CbGdCrCtD
Arsenic trioxide—TXNRD1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000133	0.0197	CbGdCrCtD
Arsenic trioxide—JUN—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000133	0.000837	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000133	0.000836	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERAP1—ankylosing spondylitis	0.000133	0.000836	CbGpPWpGaD
Arsenic trioxide—IKBKB—Apoptosis—TNF—ankylosing spondylitis	0.000132	0.000829	CbGpPWpGaD
Arsenic trioxide—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000132	0.000829	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000131	0.000827	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-C—ankylosing spondylitis	0.000131	0.000824	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CARD9—ankylosing spondylitis	0.00013	0.00082	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00013	0.0193	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00013	0.0193	CbGdCrCtD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000129	0.000816	CbGpPWpGaD
Arsenic trioxide—MAPK1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000128	0.000806	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000128	0.000805	CbGpPWpGaD
Arsenic trioxide—AKT1—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000128	0.000804	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1R2—ankylosing spondylitis	0.000127	0.000802	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERAP1—ankylosing spondylitis	0.000126	0.000795	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.000126	0.000791	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CARD9—ankylosing spondylitis	0.000125	0.000788	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000124	0.000784	CbGpPWpGaD
Arsenic trioxide—MAPK3—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000124	0.00078	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.000123	0.000778	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.000123	0.000778	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisone—ankylosing spondylitis	0.000123	0.0183	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisone—ankylosing spondylitis	0.000123	0.0183	CbGdCrCtD
Arsenic trioxide—IKBKB—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000122	0.000771	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000122	0.000766	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CARD9—ankylosing spondylitis	0.000121	0.000764	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERAP1—ankylosing spondylitis	0.000121	0.000761	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00012	0.0179	CbGdCrCtD
Arsenic trioxide—TXNRD1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00012	0.0179	CbGdCrCtD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-C—ankylosing spondylitis	0.000119	0.00075	CbGpPWpGaD
Arsenic trioxide—MAPK1—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000118	0.000742	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000116	0.000733	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CARD9—ankylosing spondylitis	0.000115	0.000727	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000114	0.00072	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000113	0.00071	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CARD9—ankylosing spondylitis	0.00011	0.000696	CbGpPWpGaD
Arsenic trioxide—MAPK3—Spinal Cord Injury—TNF—ankylosing spondylitis	0.00011	0.000694	CbGpPWpGaD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TNF—ankylosing spondylitis	0.000105	0.00066	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000104	0.000653	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000103	0.000647	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	9.96e-05	0.000628	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD79A—ankylosing spondylitis	9.87e-05	0.000622	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—B3GNT2—ankylosing spondylitis	9.81e-05	0.000619	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	9.66e-05	0.000609	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—B3GNT2—ankylosing spondylitis	9.52e-05	0.0006	CbGpPWpGaD
Arsenic trioxide—JUN—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	9.45e-05	0.000596	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	9.19e-05	0.000579	CbGpPWpGaD
Arsenic trioxide—AKT1—Apoptosis—TNF—ankylosing spondylitis	9.13e-05	0.000575	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—B3GNT2—ankylosing spondylitis	9.06e-05	0.000571	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TNF—ankylosing spondylitis	8.91e-05	0.000561	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	8.79e-05	0.000554	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.79e-05	0.000554	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD79A—ankylosing spondylitis	8.72e-05	0.000549	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TNF—ankylosing spondylitis	8.56e-05	0.000539	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TNF—ankylosing spondylitis	8.3e-05	0.000523	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HLA-B—ankylosing spondylitis	8.3e-05	0.000523	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—B3GNT2—ankylosing spondylitis	8.22e-05	0.000518	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-C—ankylosing spondylitis	8.17e-05	0.000515	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD40LG—ankylosing spondylitis	8.05e-05	0.000507	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	8.04e-05	0.000507	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.98e-05	0.000503	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HLA-B—ankylosing spondylitis	7.97e-05	0.000502	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TNF—ankylosing spondylitis	7.9e-05	0.000498	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-C—ankylosing spondylitis	7.85e-05	0.000495	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.74e-05	0.000488	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HLA-B—ankylosing spondylitis	7.73e-05	0.000487	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.72e-05	0.000487	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-B—ankylosing spondylitis	7.65e-05	0.000482	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-C—ankylosing spondylitis	7.61e-05	0.00048	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TNF—ankylosing spondylitis	7.56e-05	0.000476	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.49e-05	0.000472	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.36e-05	0.000464	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HLA-B—ankylosing spondylitis	7.36e-05	0.000464	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CRP—ankylosing spondylitis	7.33e-05	0.000462	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP3—ankylosing spondylitis	7.31e-05	0.000461	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-C—ankylosing spondylitis	7.25e-05	0.000457	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	7.13e-05	0.000449	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD40LG—ankylosing spondylitis	7.11e-05	0.000448	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1RN—ankylosing spondylitis	7.1e-05	0.000447	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HLA-A—ankylosing spondylitis	7.09e-05	0.000447	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CRP—ankylosing spondylitis	7.05e-05	0.000444	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HLA-B—ankylosing spondylitis	7.04e-05	0.000444	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—TLR4—ankylosing spondylitis	7.03e-05	0.000443	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-C—ankylosing spondylitis	6.93e-05	0.000437	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CRP—ankylosing spondylitis	6.83e-05	0.000431	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—B3GNT2—ankylosing spondylitis	6.83e-05	0.000431	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1RN—ankylosing spondylitis	6.82e-05	0.00043	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-B—ankylosing spondylitis	6.76e-05	0.000426	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—TLR4—ankylosing spondylitis	6.75e-05	0.000426	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1RN—ankylosing spondylitis	6.61e-05	0.000417	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—TLR4—ankylosing spondylitis	6.55e-05	0.000413	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CRP—ankylosing spondylitis	6.5e-05	0.00041	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	6.4e-05	0.000403	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1RN—ankylosing spondylitis	6.29e-05	0.000397	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HLA-A—ankylosing spondylitis	6.26e-05	0.000395	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—TLR4—ankylosing spondylitis	6.23e-05	0.000393	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD79A—ankylosing spondylitis	6.23e-05	0.000393	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CRP—ankylosing spondylitis	6.22e-05	0.000392	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1RN—ankylosing spondylitis	6.02e-05	0.00038	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD79A—ankylosing spondylitis	5.99e-05	0.000377	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—TLR4—ankylosing spondylitis	5.96e-05	0.000376	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD79A—ankylosing spondylitis	5.81e-05	0.000366	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.68e-05	0.000358	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD79A—ankylosing spondylitis	5.53e-05	0.000348	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—MMP3—ankylosing spondylitis	5.51e-05	0.000347	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD79A—ankylosing spondylitis	5.29e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.24e-05	0.00033	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1A—ankylosing spondylitis	5.11e-05	0.000322	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD40LG—ankylosing spondylitis	5.08e-05	0.00032	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1A—ankylosing spondylitis	4.91e-05	0.000309	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTGER4—ankylosing spondylitis	4.91e-05	0.000309	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD40LG—ankylosing spondylitis	4.88e-05	0.000308	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-B—ankylosing spondylitis	4.83e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1A—ankylosing spondylitis	4.76e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD40LG—ankylosing spondylitis	4.73e-05	0.000298	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.71e-05	0.000297	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-B—ankylosing spondylitis	4.64e-05	0.000293	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTGER4—ankylosing spondylitis	4.57e-05	0.000288	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1A—ankylosing spondylitis	4.53e-05	0.000286	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD40LG—ankylosing spondylitis	4.5e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-B—ankylosing spondylitis	4.5e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-A—ankylosing spondylitis	4.48e-05	0.000282	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.35e-05	0.000274	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1A—ankylosing spondylitis	4.33e-05	0.000273	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD40LG—ankylosing spondylitis	4.31e-05	0.000272	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-A—ankylosing spondylitis	4.3e-05	0.000271	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-B—ankylosing spondylitis	4.28e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—ankylosing spondylitis	4.27e-05	0.000269	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	4.21e-05	0.000265	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-A—ankylosing spondylitis	4.17e-05	0.000263	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTGER4—ankylosing spondylitis	4.16e-05	0.000262	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—ankylosing spondylitis	4.1e-05	0.000259	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-B—ankylosing spondylitis	4.1e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TLR4—ankylosing spondylitis	4.1e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—ankylosing spondylitis	3.98e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HLA-A—ankylosing spondylitis	3.97e-05	0.00025	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-A—ankylosing spondylitis	3.97e-05	0.00025	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TLR4—ankylosing spondylitis	3.93e-05	0.000248	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HLA-A—ankylosing spondylitis	3.85e-05	0.000243	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TLR4—ankylosing spondylitis	3.82e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-A—ankylosing spondylitis	3.8e-05	0.000239	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—ankylosing spondylitis	3.79e-05	0.000239	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HLA-A—ankylosing spondylitis	3.67e-05	0.000231	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TLR4—ankylosing spondylitis	3.63e-05	0.000229	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—ankylosing spondylitis	3.62e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—ankylosing spondylitis	3.61e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—ankylosing spondylitis	3.5e-05	0.000221	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP3—ankylosing spondylitis	3.49e-05	0.00022	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TLR4—ankylosing spondylitis	3.47e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.36e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP3—ankylosing spondylitis	3.36e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—ankylosing spondylitis	3.33e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP3—ankylosing spondylitis	3.26e-05	0.000205	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.16e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP3—ankylosing spondylitis	3.1e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP3—ankylosing spondylitis	2.96e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.07e-05	0.000131	CbGpPWpGaD
